<?xml version="1.0" encoding="UTF-8"?>
<mods xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
      version="3.7"
      xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-7.xsd">
   <titleInfo>
      <title>Focus on the high therapeutic potentials of quercetin and its derivatives</title>
   </titleInfo>
   <name type="personal" usage="primary">
      <namePart type="given">Axelle</namePart>
      <namePart type="family">Septembre-Malaterre</namePart>
      <displayForm>Septembre-Malaterre, Axelle</displayForm>
      <affiliation>Université de La Réunion, Unité de recherche Etudes Pharmaco-Immunologie (EPI), CHU La Réunion site Félix Guyon, Allée des Topazes, CS11021, 97400 Saint Denis de La Réunion, France</affiliation>
      <affiliation>Laboratoire d'immunologie clinique et expérimentale de la zone de l'océan indien (LICE-OI) CHU La Réunion site Félix Guyon, Allée des Topazes, CS11021, 97400 Saint Denis de La Réunion, France</affiliation>
      <role>
         <roleTerm type="text">author</roleTerm>
      </role>
   </name>
   <name type="personal">
      <namePart type="given">Ahcène</namePart>
      <namePart type="family">Boumendjel</namePart>
      <displayForm>Boumendjel, Ahcène</displayForm>
      <affiliation>Université Grenoble Alpes, INSERM, LRB, 38000 Grenoble, France</affiliation>
      <role>
         <roleTerm type="text">author</roleTerm>
      </role>
   </name>
   <name type="personal">
      <namePart type="given">Anne-Laure Sandenon</namePart>
      <namePart type="family">Seteyen</namePart>
      <displayForm>Seteyen, Anne-Laure Sandenon</displayForm>
      <affiliation>Université de La Réunion, Unité de recherche Etudes Pharmaco-Immunologie (EPI), CHU La Réunion site Félix Guyon, Allée des Topazes, CS11021, 97400 Saint Denis de La Réunion, France</affiliation>
      <role>
         <roleTerm type="text">author</roleTerm>
      </role>
   </name>
   <name type="personal">
      <namePart type="given">Chailas</namePart>
      <namePart type="family">Boina</namePart>
      <displayForm>Boina, Chailas</displayForm>
      <affiliation>Université de La Réunion, Unité de recherche Etudes Pharmaco-Immunologie (EPI), CHU La Réunion site Félix Guyon, Allée des Topazes, CS11021, 97400 Saint Denis de La Réunion, France</affiliation>
      <affiliation>Laboratoire d'immunologie clinique et expérimentale de la zone de l'océan indien (LICE-OI) CHU La Réunion site Félix Guyon, Allée des Topazes, CS11021, 97400 Saint Denis de La Réunion, France</affiliation>
      <role>
         <roleTerm type="text">author</roleTerm>
      </role>
   </name>
   <name type="personal">
      <namePart type="given">Philippe</namePart>
      <namePart type="family">Gasque</namePart>
      <displayForm>Gasque, Philippe</displayForm>
      <affiliation>Université de La Réunion, Unité de recherche Etudes Pharmaco-Immunologie (EPI), CHU La Réunion site Félix Guyon, Allée des Topazes, CS11021, 97400 Saint Denis de La Réunion, France</affiliation>
      <affiliation>Laboratoire d'immunologie clinique et expérimentale de la zone de l'océan indien (LICE-OI) CHU La Réunion site Félix Guyon, Allée des Topazes, CS11021, 97400 Saint Denis de La Réunion, France</affiliation>
      <role>
         <roleTerm type="text">author</roleTerm>
      </role>
   </name>
   <name type="personal">
      <namePart type="given">Pascale</namePart>
      <namePart type="family">Guiraud</namePart>
      <displayForm>Guiraud, Pascale</displayForm>
      <affiliation>Université de La Réunion, Unité de recherche Etudes Pharmaco-Immunologie (EPI), CHU La Réunion site Félix Guyon, Allée des Topazes, CS11021, 97400 Saint Denis de La Réunion, France</affiliation>
      <role>
         <roleTerm type="text">author</roleTerm>
      </role>
   </name>
   <name type="personal">
      <namePart type="given">Jimmy</namePart>
      <namePart type="family">Sélambarom</namePart>
      <displayForm>Sélambarom, Jimmy</displayForm>
      <affiliation>Université de La Réunion, Unité de recherche Etudes Pharmaco-Immunologie (EPI), CHU La Réunion site Félix Guyon, Allée des Topazes, CS11021, 97400 Saint Denis de La Réunion, France</affiliation>
      <role>
         <roleTerm type="text">author</roleTerm>
      </role>
   </name>
   <typeOfResource>text</typeOfResource>
   <genre>article</genre>
   <originInfo>
      <dateIssued encoding="w3cdtf" keyDate="yes">2022-02</dateIssued>
   </originInfo>
   <language>
      <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
      <languageTerm type="text">English</languageTerm>
   </language>
   <abstract>Polyphenols and particularly flavonoids are of constant interest to the scientific community. Flavonoids are investigated for their biological and pharmacological purposes, notably as antioxidant, anticancer, antiviral and for their anti-inflammatory activities. Certainly, one of the best-known flavonols recognized for its therapeutic and preventive properties, is quercetin. Despite its biological interest, quercetin suffer from some drawbacks, mainly related to its bioavailability. Hence, its synthetic or biosynthetic derivatives have been the subject of intensive research. The health-promoting biological activities of flavonols and derivatives mainly arise from their capacity to disrupt the host-pathogen interactions and/or to regulate host cellular functions including oxidative processes and immunological responses. In the age of coronavirus pandemic, the anti-inflammatory and antiviral potential of flavonols should be put forward to explore these substances for decreasing the viral load and inflammatory storm caused by the infection. The present review will decipher and discuss the antioxidant, anti-inflammatory and antiviral capacities of major flavonol with a focus on the molecular basis and structure-activity relationships. Current study used a combination of quercetin derivatives, pathway, antioxidant, anti-inflammatory, antiviral activities as keywords to retrieve the literature. This study critically reviewed the current literature and presented the ability of natural analogs of quercetin having superior antioxidant, anti-inflammatory and antiviral effects than the original molecule. This review allowed the identification of relevant key structure-activity relationship elements and highlight approaches on the mechanisms governing the antioxidant, antiviral and anti-inflammatory activities. Through a critical analysis of the literature, flavonols and more precisely quercetin derivatives reviewed and found to act simultaneously on inflammation, virus and oxidative stress, three key factors that may lead to life threatening diseases. </abstract>
   <subject>
      <topic>Flavonols</topic>
   </subject>
   <subject>
      <topic>Quercetin</topic>
   </subject>
   <subject>
      <topic>Flavonol derivatives</topic>
   </subject>
   <subject>
      <topic>Antioxidant</topic>
   </subject>
   <subject>
      <topic>Antiviral</topic>
   </subject>
   <subject>
      <topic>Anti-inflammatory</topic>
   </subject>
   <relatedItem type="host">
      <titleInfo>
         <title>Phytomedicine Plus</title>
      </titleInfo>
      <originInfo>
         <publisher>Elsevier B.V.</publisher>
      </originInfo>
      <identifier type="issn">2667-0313</identifier>
      <part>
         <detail type="volume">
            <number>2</number>
            <caption>v.</caption>
         </detail>
         <detail type="issue">
            <number>1</number>
            <caption>no.</caption>
         </detail>
         <text type="display-date">February 2022</text>
         <text type="year">2022</text>
         <text type="month">February</text>
         <extent unit="pages">
            <start>100220</start>
         </extent>
      </part>
   </relatedItem>
   <identifier type="doi">10.1016/j.phyplu.2022.100220</identifier>
   <location>
      <url>http://dx.doi.org/10.1016/j.phyplu.2022.100220</url>
   </location>
   <identifier type="pii">S2667-0313(22)00006-9</identifier>
   <accessCondition type="use and reproduction"
                    displayLabel="Creative Commons Attribution 4.0 Generic (CC BY-NC-ND 4.0)">
      <program xmlns="https://data.crossref.org/schemas/AccessIndicators.xsd">
         <licence_ref applies_to="reuse" start_date="2022-01-13"/>
         <licence_ref>http://creativecommons.org/licenses/by-nc-nd/4.0/</licence_ref>
      </program>
   </accessCondition>
   <extension>
      <vendorName/>
      <archiveFile/>
      <originalFile>file:/C:/Users/Carlos.Martinez/OneDrive%20-%20USDA/XML_projects/OpenAccess/OpenAccess/transform/source/sourcefiles/576450669703096969-00001/2667-0313/S2667031321X00061/S2667031322000069/S2667031322000069.xml</originalFile>
      <workingDirectory>C:\Users\Carlos.Martinez\OneDrive - USDA\XML_projects\OpenAccess\OpenAccess\transform\result\</workingDirectory>
   </extension>
</mods>
